Common Stock	9 Months Ended
Feb. 28, 2025
Equity [Abstract]
Common Stock [Text Block]	6. Common Stock Authorized 250,000,000 shares of common stock, $0.001 par value Issued and outstanding As at February 28, 2025, there were 125,224,373 shares of common stock issued and outstanding (May 31, 2024 - 100,974,373). As at the date of these financial statements, the Company has recorded shares issuable of $106,667 (May 31, 2024 -$357,862) relating to proceeds received or settlement of debt for 5,920,000 (May 31, 2024 - 15,560,000) shares of common stock which have yet to be issued. Stock transactions during the nine months ended February 28, 2025: (a) During the nine months ended February 28, 2025, the Company received proceeds of $106,667 (Cdn$148,000) for 5,920,000 shares of common stock at Cdn$0.025 per share to be issued subsequent to the period end. (b) On September 10, 2024, the Company issued 100,000 shares of common stock at a price of $0.025 per share for proceeds of $2,500, 500,000 shares of common stock at a price of $0.02 per share for proceeds of $10,000 and 15,260,000 shares of common stock at a price of Cdn$0.025 per share for proceeds of $36,706 (Cdn$50,000) and to settle shares issuable of $244,862 (Cdn$331,500), of which 2,600,000 shares were issued to a director and a company controlled by the director of the Company and 800,000 shares were issued to individuals related to a director of the Company. (c) On September 10, 2024, the Company issued 2,300,000 shares of common stock, of which 1,200,000 shares were issued to a director of the Company, to settle shares issuable of $113,000 relating to settlement agreements entered into during the year ended May 31, 2024. (d) On August 31, 2024, a company controlled by the CEO of the Company assigned its outstanding receivables of $19,452 (Cdn$26,250), owed to it by the Company to six third-party individuals and an individual related to the CEO of the Company. On August 31, 2024, a company controlled by the CFO of the Company assigned its outstanding receivables of $3,705 (Cdn$5,000), owed to it by the Company to a third-party individual. Following these assignments, the Company entered into a settlement agreement with these third-party individuals and the individual related to the CEO of the Company and agreed to settle the assigned amounts by issuing an aggregate of 1,250,000 shares of its common stock. Upon settlement, the Company recognized a loss on settlement of $28,092. On September 10, 2024, the Company issued 1,250,000 shares of common stock, of which 200,000 shares were issued to an individual related to the CEO of the Company. (e) On August 31, 2024, a director of the Company assigned its outstanding receivables of $3,705 (Cdn$5,000), owed to it by the Company to a third-party individual. Following this assignment, the Company entered into a settlement agreement with the third-party individual and agreed to settle the assigned amount by issuing an aggregate of 200,000 shares of its common stock. Upon settlement, the Company recognized a loss on settlement of $4,495. On September 26, 2024, the Company issued 200,000 shares of common stock. (f) On August 31, 2024, the Company entered into settlement agreements with a director of the Company and an individual related to the director of the Company to settle accounts payable of $37,793 (Cdn$51,000) by issuing an aggregate of 2,040,000 shares of common stock. Upon settlement, the Company recognized a loss on settlement of $45,847. On September 10, 2024, the Company issued 2,040,000 shares of common stock, of which 2,000,000 shares were issued to a director of the Company and 40,000 shares were issued to an individual related to the director of the Company. (g) On August 31, 2024, the Company entered into settlement agreements with 10 third-party individuals to settle accounts payable of $48,168 (Cdn$65,000) by issuing an aggregate of 2,600,000 shares of common stock. Upon settlement, the Company recognized a loss on settlement of $58,432. On September 10, 2024, the Company issued 2,600,000 shares of common stock. Stock transactions during the nine months ended February 29, 2024: (h) During the nine months ended February 29, 2024, the Company recorded $301,750 (Cdn$404,000) for the issuance of 16,160,000 shares of common stock at Cdn$0.025 per share and $10,000 for the issuance of 500,000 shares of common stock at $0.02 per share. (i) On September 6, 2023, the Company issued 9,810,000 shares of common stock to settle subscription payable of $185,290. (j) On September 6, 2023, the Company issued 140,000 shares of common stock to settle related parties payable of $2,637 (Cdn$3,500). On July 18, 2023 and August 10, 2023, a company controlled by the CEO of the Company assigned its outstanding receivables of $746 (Cdn$1,000) and $1,891 (Cdn$2,500), respectively, owed to it by the Company to two third-party individuals. Following this assignment, the Company entered into a Settlement Agreement with these two third-party individuals and agreed to settle the assigned amount by issuing an aggregate of 140,000 shares of its common stock. Upon settlement the Company recognized a loss on settlement of $543. (k) On December 7, 2023, the Company entered into a Settlement Agreement with a third-party individual and agreed to settle accounts payable of $1,839 (Cdn$2,500) by issuing 100,000 shares of its common stock at a fair value of $3,000. As a result, the Company recognized a loss on settlement of $1,161. At February 28, 2025 and February 29, 2024, the Company had no dilutive shares, or common stock equivalents.

6. Common Stock

Authorized

250,000,000 shares of common stock, $0.001 par value

Issued and outstanding

As at February 28, 2025, there were 125,224,373 shares of common stock issued and outstanding (May 31, 2024 - 100,974,373).

As at the date of these financial statements, the Company has recorded shares issuable of $106,667 (May 31, 2024 -$357,862) relating to proceeds received or settlement of debt for 5,920,000 (May 31, 2024 - 15,560,000) shares of common stock which have yet to be issued.

Stock transactions during the nine months ended February 28, 2025:

(a) During the nine months ended February 28, 2025, the Company received proceeds of $106,667 (Cdn$148,000) for 5,920,000 shares of common stock at Cdn$0.025 per share to be issued subsequent to the period end.

(b) On September 10, 2024, the Company issued 100,000 shares of common stock at a price of $0.025 per share for proceeds of $2,500, 500,000 shares of common stock at a price of $0.02 per share for proceeds of $10,000 and 15,260,000 shares of common stock at a price of Cdn$0.025 per share for proceeds of $36,706 (Cdn$50,000) and to settle shares issuable of $244,862 (Cdn$331,500), of which 2,600,000 shares were issued to a director and a company controlled by the director of the Company and 800,000 shares were issued to individuals related to a director of the Company.

(c) On September 10, 2024, the Company issued 2,300,000 shares of common stock, of which 1,200,000 shares were issued to a director of the Company, to settle shares issuable of $113,000 relating to settlement agreements entered into during the year ended May 31, 2024.

(d) On August 31, 2024, a company controlled by the CEO of the Company assigned its outstanding receivables of $19,452 (Cdn$26,250), owed to it by the Company to six third-party individuals and an individual related to the CEO of the Company. On August 31, 2024, a company controlled by the CFO of the Company assigned its outstanding receivables of $3,705 (Cdn$5,000), owed to it by the Company to a third-party individual. Following these assignments, the Company entered into a settlement agreement with these third-party individuals and the individual related to the CEO of the Company and agreed to settle the assigned amounts by issuing an aggregate of 1,250,000 shares of its common stock. Upon settlement, the Company recognized a loss on settlement of $28,092. On September 10, 2024, the Company issued 1,250,000 shares of common stock, of which 200,000 shares were issued to an individual related to the CEO of the Company.

(e) On August 31, 2024, a director of the Company assigned its outstanding receivables of $3,705 (Cdn$5,000), owed to it by the Company to a third-party individual. Following this assignment, the Company entered into a settlement agreement with the third-party individual and agreed to settle the assigned amount by issuing an aggregate of 200,000 shares of its common stock. Upon settlement, the Company recognized a loss on settlement of $4,495. On September 26, 2024, the Company issued 200,000 shares of common stock.

(f) On August 31, 2024, the Company entered into settlement agreements with a director of the Company and an individual related to the director of the Company to settle accounts payable of $37,793 (Cdn$51,000) by issuing an aggregate of 2,040,000 shares of common stock. Upon settlement, the Company recognized a loss on settlement of $45,847. On September 10, 2024, the Company issued 2,040,000 shares of common stock, of which 2,000,000 shares were issued to a director of the Company and 40,000 shares were issued to an individual related to the director of the Company.

(g) On August 31, 2024, the Company entered into settlement agreements with 10 third-party individuals to settle accounts payable of $48,168 (Cdn$65,000) by issuing an aggregate of 2,600,000 shares of common stock. Upon settlement, the Company recognized a loss on settlement of $58,432. On September 10, 2024, the Company issued 2,600,000 shares of common stock.

Stock transactions during the nine months ended February 29, 2024:

(h) During the nine months ended February 29, 2024, the Company recorded $301,750 (Cdn$404,000) for the issuance of 16,160,000 shares of common stock at Cdn$0.025 per share and $10,000 for the issuance of 500,000 shares of common stock at $0.02 per share.

(i) On September 6, 2023, the Company issued 9,810,000 shares of common stock to settle subscription payable of $185,290.

(j) On September 6, 2023, the Company issued 140,000 shares of common stock to settle related parties payable of $2,637 (Cdn$3,500). On July 18, 2023 and August 10, 2023, a company controlled by the CEO of the Company assigned its outstanding receivables of $746 (Cdn$1,000) and $1,891 (Cdn$2,500), respectively, owed to it by the Company to two third-party individuals. Following this assignment, the Company entered into a Settlement Agreement with these two third-party individuals and agreed to settle the assigned amount by issuing an aggregate of 140,000 shares of its common stock. Upon settlement the Company recognized a loss on settlement of $543.

(k) On December 7, 2023, the Company entered into a Settlement Agreement with a third-party individual and agreed to settle accounts payable of $1,839 (Cdn$2,500) by issuing 100,000 shares of its common stock at a fair value of $3,000. As a result, the Company recognized a loss on settlement of $1,161.

At February 28, 2025 and February 29, 2024, the Company had no dilutive shares, or common stock equivalents.